Esperion Therapeutics, Inc. short interest in 2026
In 2026, Esperion Therapeutics, Inc.'s disclosed short interest ran from 15.66% of shares outstanding on 15 Jan 2026 to 6.76% on 30 Jun 2026, a change of -8.90 percentage points. The year's high was 15.66% on 15 Jan 2026 and its low 6.76% on 30 Jun 2026, averaging 11.68% across 12 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.60 days on 27 Feb 2026. Full history: Esperion Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 15.66% (15 Jan 2026)
- End of year
- 6.76% (30 Jun 2026)
- Change
- -8.90 pp
- High
- 15.66% (15 Jan 2026)
- Low
- 6.76% (30 Jun 2026)
- Average
- 11.68%
- Highest days to cover
- 13.60 (27 Feb 2026)
- SEC filings marked
- 4
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 15.66% | 5.88 | results (8-K) |
| 30 Jan 2026 | 13.99% | 6.52 | |
| 13 Feb 2026 | 14.04% | 9.38 | |
| 27 Feb 2026 | 14.02% | 13.60 | |
| 13 Mar 2026 | 13.13% | 5.05 | 10-K filed, results (8-K) |
| 31 Mar 2026 | 12.90% | 6.98 | |
| 15 Apr 2026 | 12.39% | 3.73 | |
| 30 Apr 2026 | 14.15% | 5.18 | |
| 15 May 2026 | 7.85% | 1.00 | 10-Q filed |
| 29 May 2026 | 7.27% | 2.68 | |
| 15 Jun 2026 | 8.05% | 1.76 | |
| 30 Jun 2026 | 6.76% | 1.74 |
See also: Esperion Therapeutics, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.